Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women

Key facts

Sponsor

BioNet-Asia Co., Ltd.

Principal Investigator

Soaud Mansouri, PhD.

Bionet-Asia Co., Ltd (Branch1)

Enrollment

2700 enrolled

Eligibility

FEMALE

Timeline

2024 – 2025

Study locations (1)

• Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Bangkok, Thailand

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Whooping cough

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT06827470
  Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
  Dalhousie University
• RECRUITINGPHASE4NCT06803524
  10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
  Mahidol University
• ACTIVE NOT RECRUITINGPHASE3NCT06798831
  Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults
  BioNet-Asia Co., Ltd.
• RECRUITINGPHASE4NCT06903221
  A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection
  Dimitri Diavatopoulos
• RECRUITINGNCT06286007
  Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
  Hospital Clinico Universitario de Santiago
• RECRUITINGNANCT05897879
  Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
  Institut Pasteur
• RECRUITINGNANCT05847322
  Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
  University of Southampton
• ACTIVE NOT RECRUITINGPHASE4NCT05264662
  Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
  Farzanah Laher

See all trials for Whooping cough →